Gilead Sciences Inc. (GILD): Share Price, Stock Analysis, Annual Report | Value Research Get Gilead Sciences Inc. (GILD)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Drugs & Pharma

Gilead Sciences Inc. (GILD)

NASDAQ: GILD

  • Market Capitalisation info

    $78,912 Mln


  • 12 Month Earnings info

    $4,137 Mln

  • Price to Earnings info

    19.25

$66.54

As on 17-Aug-2022 13:36 EDT

up-down-arrow $0.210.31%

  • Prev Close info

    $66.33

  • Day's Openinfo

    $65.97

  • Today's Highinfo

    $66.74

  • Today's Lowinfo

    $65.82

  • Today's Volumeinfo

    2,947,938

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Gilead Sciences (GILD)
-8.37 6.29 6.90 -7.22 1.76 -1.93 8.91
S&P 100
-10.68 10.71 7.61 -4.51 15.41 12.40 11.66
S&P BSE Healthcare
-11.15 3.06 4.16 -10.00 23.12 11.99 12.31
As on 17-Aug-2022
2021
2020
2019
2018
2017
2016
2015
Gilead Sciences (GILD)
29.95 -6.70 7.88 -9.87 2.96 -27.59 8.63
S&P 100
27.55 19.30 29.47 -5.82 19.34 8.78 0.34
S&P BSE Healthcare
20.87 61.45 -3.55 -5.89 0.49 -12.88 15.06

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        Chairman & CEO

        Mr. Daniel P. O'Day

        Exec. VP & CFO

        Mr. Andrew D. Dickinson

        Headquarters

        Foster City, CA
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $78,912.18 Mln

        • Revenue (TTM) info

          $27,515.00 Mln

        • Earnings (TTM) info

          $4,137.00 Mln

        • Cash info

          $5,663.00 Mln

        • Total Debt info

          $4,270.00 Mln

        • Insider's Holding

          0.05%

        • Liquidity info

          Low

        • 52 Week range info

          $57.17 - 74.12

        • Shares outstanding info

          1,254,310,016

        • 10 Years Aggregate:

          CFO: $105,109.70 Mln

          EBITDA: $117,503.41 Mln

          Net Profit: $71,193.37 Mln

        About The Company

        • Business

          Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

        • IPO Date

          22-Jan-1992

        • Chairman & CEO

          Mr. Daniel P. O'Day

        • Exec. VP & CFO

          Mr. Andrew D. Dickinson

        • Listing info

          NASDAQ: GILD

        • Country

          United States

        • Headquarters info

          Foster City, CA

        • Website info

          https://www.gilead.com